Literature DB >> 11876521

Seroprevalence, viremia and genotype distribution of hepatitis C virus: a community-based population study in northern Italy.

C Campello1, A Poli, Molin G Dal, F Besozzi-Valentini.   

Abstract

BACKGROUND: Our aim was to define the burden of HCV infection and the related risk factors in a sample of the general population of northern Italy.
MATERIALS AND METHODS: This is a survey on the prevalence of hepatitis C virus (HCV) infection carried out in a cohort (861 males and 1,293 females aged 17-67 years) from the general population of northern Italy.
RESULTS: The crude HCV seroprevalence rate was 3.3%, higher in females than in males (p < 0.01) and with a clear age-related effect (test for linear trend: p < 0.01). When adjusted for sex and age in relation to the reference population, the prevalence was 3.7% (95% CI: 2.9-4.5%). In the univariate analysis, HCV infection was related to intravenous drug use (IVDU) (p < 0.001); transfusion (p < 0.001); tattooing (p = 0.02); chiropodist/manicure (p < 0.001); number of children (p < 0.01); educational level (p < 0.001). In the multivariate analysis sex, age over 50 years, transfusion, IVDU and tattooing were confirmed as risk factors, while the educational level seems to be a protective factor. Separate multivariate analysis for males and females points out that the age shift, the protective effect of education and the number of children as risk factor were present only in females. HCV viremia was detected in the 71.8% of the seropositive, resulting in an infection rate of 2.4% (95% CI: 1.7-3.0%). Genotype 1b accounted for 64.7% of isolates.
CONCLUSION: In the general population of our area, HCV infection is mesoendemic and current infections are mostly sustained by genotype 1b.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11876521     DOI: 10.1007/s15010-001-1197-4

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  14 in total

1.  High seroprevalence of HCV in the Abruzzo Region, Italy: results on a large sample from opt-out pre-surgical screening.

Authors:  Ennio Polilli; Monica Tontodonati; Maria Elena Flacco; Tamara Ursini; Palmira Striani; Dante Di Giammartino; Maurizio Paoloni; Luigi Vallarola; Gabriella Lucidi Pressanti; Giorgia Fragassi; Patrizia Accorsi; Lamberto Manzoli; Giustino Parruti
Journal:  Infection       Date:  2015-09-12       Impact factor: 3.553

2.  Intrafamilial transmission of hepatitis C virus infection.

Authors:  Eliseo Minola; Vincenzo Baldo; Tatjana Baldovin; Renzo Trivello; Annarosa Floreani
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

Review 3.  Transmission of hepatitis C virus infection through tattooing and piercing: a critical review.

Authors:  Rania A Tohme; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2012-01-30       Impact factor: 9.079

4.  Prevalence of hepatitis C infection in a population of asymptomatic people in a checkup unit in Mexico city.

Authors:  Nahum Méndez-Sánchez; Guadalupe Ponciano-Rodriguez; Norberto C Chávez-Tapia; Daniel Motola-Kuba; Paloma Almeda-Valdes; Karla Sánchez-Lara; Martha H Ramos; Misael Uribe
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

5.  Hepatitis C virus infection in Italian patients with fibromyalgia.

Authors:  C Palazzi; E D'Amico; S D'Angelo; A Nucera; A Petricca; I Olivieri
Journal:  Clin Rheumatol       Date:  2007-10-18       Impact factor: 2.980

Review 6.  Epidemiology of hepatitis C virus infection.

Authors:  Miriam J Alter
Journal:  World J Gastroenterol       Date:  2007-05-07       Impact factor: 5.742

7.  Outcome of combination antiviral therapy in chronic hepatitis C virus infection during therapy of acute lymphoblastic leukemia.

Authors:  Muhammad Ayyub; Soha A El-Moursy; Fahd Al-Abbas
Journal:  Saudi J Gastroenterol       Date:  2011 Jul-Aug       Impact factor: 2.485

8.  Hepatitis C Virus infections trends in Italy, 1996-2006.

Authors:  Giuseppe La Torre; Maria Rosaria Gualano; Leda Semyonov; Nicola Nicolotti; Walter Ricciardi; Antonio Boccia
Journal:  Hepat Mon       Date:  2011-11-30       Impact factor: 0.660

Review 9.  Outcomes of hepatitis C screening programs targeted at risk groups hidden in the general population: a systematic review.

Authors:  Freke R Zuure; Anouk T Urbanus; Miranda W Langendam; Charles W Helsper; Charlotte H S B van den Berg; Udi Davidovich; Maria Prins
Journal:  BMC Public Health       Date:  2014-01-22       Impact factor: 3.295

Review 10.  Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.

Authors:  Susan J M Hahné; Irene K Veldhuijzen; Lucas Wiessing; Tek-Ang Lim; Mika Salminen; Marita van de Laar
Journal:  BMC Infect Dis       Date:  2013-04-18       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.